AstraZeneca Pharma India Share Price

AstraZeneca Share Recommendations

AstraZeneca Financials

AstraZeneca Technicals

AstraZeneca Peer Comparison

AstraZeneca Shareholding Pattern

AstraZeneca MF Ownership

• Nippon India Small Cap Direct-G

  Equity: Small Cap

  5

  • 556.76

    Amount Invested (in Cr.)

  • 0.86%

    % of AUM

  • 0.00

    % Change (MoM basis)

• Nippon India Pharma Direct-G

  Equity: Sectoral-Pharma

  3

  • 52.94

    Amount Invested (in Cr.)

  • 0.63%

    % of AUM

  • 0.00

    % Change (MoM basis)

• ICICI Pru Pharma Healthcare and Diagnostics (P.H.D) Direct-G

  Equity: Sectoral-Pharma

  4

  • 46.55

    Amount Invested (in Cr.)

  • 0.75546801%

    % of AUM

  • 0.00

    % Change (MoM basis)

AstraZeneca Corporate Actions

About AstraZeneca

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 22,020.00 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Grants for the year ending 31-Mar-2025.For the quarter ended 30-06-2025, the company has reported a Standalone Total Income of Rs 537.55 Crore, up 8.24 % from last quarter Total Income of Rs 496.63 Crore and up 35.79 % from last year same quarter Total Income of Rs 395.87 Crore. Company has reported net profit after tax of Rs 55.83 Crore in latest quarter.The company’s top management includes Ms.Shilpa Divekar Nirula, Mr.Praveen Rao Akkinepally, Ms.Bhavana Agrawal, Ms.Hooi Bien Chuah, Mr.Jesus Javier Diaz-Ropero Esteso, Ms.Sylvia Lorena Varela Ramon, Ms.Monica Widhani, Ms.Revathy Ashok, Ms.Bhavana Agrawal, Ms.Manasa Rama. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 30-06-2025, the company has a total of 2.50 Crore shares outstanding.AstraZeneca Share Price Today is Rs. 8808.00. On previous day, the AstraZeneca Share Price (NSE) closed at Rs. 8761.0, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 30th Jun, 2025, the promoter held 75.0% of the stake in AstraZeneca shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of AstraZeneca stocks was 3.03% as compared to 2.89% in Mar 2025 with increase of 0.14%. The domestic institutional investors (DII) holdings on 30th Jun, 2025 was 4.54% as compared to 4.64% in Mar 2025 with decrease of 0.1%. Out of the total DII holdings in AstraZeneca shares 4.33% was held by mutual funds. The rest including public held is 17.43%. AstraZeneca stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
AstraZeneca Dividend: Ever since 1979, AstraZeneca dividends has been paid out around 25 times. As on 24 Sep, 2025, 03:53 PM IST, The overall dividend yield for AstraZeneca stands at 0.36%. The last dividend paid was on July 18, 2025 (Rs. 32.0). The Earnings Per Share (EPS) for quarter ending 30th Jun 2025 is Rs. 73.34.

AstraZeneca Bonus: The most recent bonus issue had been in year November 13, 1995 around 29 years ago at 1 : 1 ratio. The first bonus issue was announced in Oct 1995.

Stock Forecast:
After showing 537.55 Cr. of sales and 8.24% of quarterly net profit, there have been multiple ups and downs in the AstraZeneca stock prices in the past few weeks. For example, AstraZeneca stock price on 17th of September 2025 was around Rs. 9138.0. AstraZeneca share price now stands at an average of Rs. 8808.00. Judging by last week's performance, stock is in down trend.

AstraZeneca has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for AstraZeneca share.

Historical Prices and Performance:
AstraZeneca, incorporated in 1979 is a Mid Cap company (with a market cap of Rs. 22020.0) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by AstraZeneca stock was 15.02%, 22.68%, 16.86%, 12.04% and 20.45% respectively.
The AstraZeneca share gave a 3 year return of 176.42% as compared to Nifty 50 which gave a return of 44.61%.
AstraZeneca announced 1600.0% final dividend on July 18, 2025.

Key Metrics:
PE Ratio of AstraZeneca is 120.09
Prices/Sales Ratio of AstraZeneca is 12.54
Price/Book Ratio of AstraZeneca is 28.58

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For AstraZeneca, major competitors and peers include Abbott India, GSK Pharma, Pfizer and Sanofi Consumer Healthcare India Ltd.. As of Mar 2025, the dividend yield of AstraZeneca stands at 0.36% while Abbott India, GSK Pharma, Pfizer and Sanofi Consumer Healthcare India Ltd. stand at 1.57%, 1.97%, 3.3% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 120.09 and 28.58 respectively.

Leadership of AstraZeneca :
Manasa Rama is Co. Secretary & Compl. Officer
Bhavana Agrawal is Chief Financial Officer
Shilpa Divekar Nirula is Chairperson & Independent Director
Praveen Rao Akkinepally is Managing Director
Bhavana Agrawal is Executive Director
Sylvia Lorena Varela Ramon is Non Executive Director
Hooi Bien Chuah is Non Executive Director
Jesus Javier Diaz-Ropero Esteso is Non Executive Director
Revathy Ashok is Independent Director
Monica Widhani is Independent Director


Show More